The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-(1-acetylpiperidin-4-yl)-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)-4-butylbenzenesulfonamide ID: ALA1078863
PubChem CID: 46882347
Max Phase: Preclinical
Molecular Formula: C27H37N3O3S
Molecular Weight: 483.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(C2CCN(C(C)=O)CC2)CC3)cc1
Standard InChI: InChI=1S/C27H37N3O3S/c1-3-4-5-22-6-10-27(11-7-22)34(32,33)28-25-9-8-23-12-16-30(17-13-24(23)20-25)26-14-18-29(19-15-26)21(2)31/h6-11,20,26,28H,3-5,12-19H2,1-2H3
Standard InChI Key: BNGJUFOQKFIMHD-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
0.0623 -10.6049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0610 -11.4289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7709 -11.8399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7689 -10.1939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4005 -10.9913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9784 -10.2029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1435 -10.0614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0402 -11.7866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1997 -11.9868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4894 -11.4311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4840 -10.6010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6509 -11.8385 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3616 -11.4268 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.9583 -10.7144 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7797 -10.7144 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.0762 -11.8325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7844 -11.4135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4985 -11.8184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5050 -12.6409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7914 -13.0569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0802 -12.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2188 -13.0474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9277 -12.6324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6415 -13.0388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.3504 -12.6239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2944 -10.9617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7648 -11.7225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6548 -11.6951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0804 -10.9082 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6092 -10.1468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7123 -10.1725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9747 -10.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4446 -11.6433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3992 -10.0943 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16 17 2 0
5 6 1 0
17 18 1 0
6 7 1 0
18 19 2 0
5 8 1 0
19 20 1 0
9 10 1 0
20 21 2 0
21 16 1 0
10 11 1 0
19 22 1 0
11 7 1 0
22 23 1 0
8 9 1 0
23 24 1 0
2 3 1 0
24 25 1 0
2 12 1 0
5 26 1 0
26 27 1 0
3 10 2 0
12 13 1 0
1 2 2 0
13 14 2 0
11 4 2 0
26 31 1 0
27 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
13 15 2 0
29 32 1 0
4 1 1 0
32 33 1 0
13 16 1 0
32 34 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 483.68Molecular Weight (Monoisotopic): 483.2556AlogP: 4.24#Rotatable Bonds: 7Polar Surface Area: 69.72Molecular Species: BASEHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.25CX Basic pKa: 9.36CX LogP: 2.80CX LogD: 1.93Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.64Np Likeness Score: -1.16
References 1. Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM.. (2009) The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor., 19 (22): [PMID:19804969 ] [10.1016/j.bmcl.2009.09.027 ]